Skip to main content
. Author manuscript; available in PMC: 2022 Sep 6.
Published in final edited form as: Nat Rev Clin Oncol. 2021 Apr 28;18(9):547–557. doi: 10.1038/s41571-021-00501-4

Fig. 1 |. Treatment of metastatic and non-metastatic NSCLC.

Fig. 1 |

Timeline showing drugs approved or indicated for the treatment of metastatic and non-metastatic non-small cell lung cancer (NSCLC) as of December 2020. When several approvals were made in a year, they are arranged chronologically from top to bottom.